ATRA

Atara Biotherapeutics Stock Analysis

AI Rating

Good
  • Quality0/10
  • Growth↑ 8/10
  • Value↑ 9/10
Atara Biotherapeutics sales and earnings growth
ATRA Growth
Good
  • Revenue Y/Y↓ -6.33%
  • EPS Y/Y↑ 122.87%
  • FCF Y/Y↑ 27.51%
Atara Biotherapeutics gross and profit margin trends
ATRA Profitability
Good
  • Gross margin ↑ 82.40%
  • EPS margin↑ 27.10%
  • ROIC 5Y↑ -142.91%
Atara Biotherapeutics net debt vs free cash flow
ATRA Risk
Poor
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 0.9
  • Interest coverage↑ 9.6

Atara Biotherapeutics stock volatility is in-line with the overall market. We give it a Poor risk rating.

More Biotechnology stocks ↗